<label id="mboud"><meter id="mboud"></meter></label>

        <rt id="mboud"><small id="mboud"><strike id="mboud"></strike></small></rt>
        咨詢熱線

        15000266580

        當(dāng)前位置:首頁(yè) >產(chǎn)品中心>細(xì)胞庫(kù)>人腫瘤細(xì)胞、癌細(xì)胞>Panc 03.27 人胰腺癌細(xì)胞

        Panc 03.27 人胰腺癌細(xì)胞

        簡(jiǎn)要描述:CRL-2549 Panc 03.27
        人胰腺癌細(xì)胞,原代細(xì)胞|細(xì)胞系|細(xì)胞株|菌種;
        細(xì)胞庫(kù)管理規(guī)范,
        提供的細(xì)胞株背景清楚,提供參考文獻(xiàn)和培養(yǎng)條件!
        Panc 03.27 人胰腺癌細(xì)胞

        • 產(chǎn)品型號(hào):
        • 廠商性質(zhì):生產(chǎn)廠家
        • 更新時(shí)間:2025-07-19
        • 訪  問(wèn)  量:2013

        產(chǎn)品分類

        Product Category

        詳細(xì)介紹

        CRL-2549 Panc 03.27 人胰腺癌細(xì)胞

        ATCC® Number: CRL-2549™ Price: $417.00

        Designations: Panc 03.27

        Depositors: EM Jaffee

        Biosafety Level: 1

        Shipped: frozen

        Medium & Serum: See Propagation

        Growth Properties: adherent

        Organism: Homo sapiens (human)

        Morphology: epithelial

        Source: Organ: pancreas

        Disease: adenocarcinoma

        Cellular Products: cytokeratins 7 and 18

        Permits/Forms: In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimay responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.


        CRL-2549 Panc 03.27 人胰腺癌細(xì)胞

        Tumorigenic: Yes

        Oncogene: K-ras + (wild-type)

        Antigen Expression: MHC class I +; MHC class II - [50655]

        Blood type A; Rh+

        DNA Profile (STR): Amelogenin: X

        CSF1PO: 10,11

        D13S317: 11,12

        D16S539: 12

        D5S818: 12,13

        D7S820: 8,13

        THO1: 6

        TPOX: 8,9

        vWA: 16,17

        Age: 65 years

        Gender: female

        Ethnicity: White

        Comments: Panc 03.27 is a pancreatic adenocarcinoma epithelial cell line derived in 1995 from a primary tumor removed from the head-of-the-pancreas of a female with pancreatic adenocarcinoma.The cells have a reported plating efficiency of 80%.

        Propagation: ATCC complete growth medium: RPMI 1640 medium with 2 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate, 4.5 g/L glucose, 10 mM HEPES, and 1.0 mM sodium pyruvate and supplemented with 10 Units/ml human insulin, 85%; fetal bovine serum, 15%

        Atmosphere: air, 95%; carbon dioxide (CO2), 5%

        Temperature: 37.0°C

        Subculturing: Protocol:

        1.Remove and discard culture medium.

        2.Briefly rinse the cell layer with 0.25% (w/v) Trypsin - 0.53 mM EDTA solution to remove all traces of serum which contains trypsin inhibitor.

        3.Add 2.0 to 3.0 ml of Trypsin-EDTA solution to flask and observe cells under an inverted microscope until cell layer is dispersed (usually within 5 to 15 minutes).

        Note: To avoid clumping do not agitate the cells by hitting or shaking the flask while waiting for the cells to detach. Cells that are difficult to detach may be placed at 37C to facilitate dispersal.

        4.Add 6.0 to 8.0 ml of complete growth medium and aspirate cells by gently pipetting.

        5.Add appropriate aliquots of the cell suspension to new culture vessels.

        6.Incubate cultures at 37C.

        Subc*tion Ratio: A subc*tion ratio of 1:3 to 1:4 is recommended

        Medium Renewal: Every 2 to 3 days

        Preservation: Freeze medium: culture medium, 95%; DMSO, 5%

        Storage temperature: liquid nitrogen vapor phase

        Doubling Time: 37.5 hrs

        Related Products: Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2001

        recommended serum:ATCC 30-2020

        0.25% (w/v) Trypsin - 0.53 mM EDTA in Hank' BSS (w/o Ca++, Mg++):ATCC 30-2101

        Cell culture tested DMSO:ATCC 4-X

        References: 50655: Jaffee EM, et al. Development and characterization of a cytokine-secreting pancreatic adenocarcinoma vaccine from primary tumors for use in clinical trials. Cancer J. Sci. Am. 4: 194-203, 1998. PubMed: 9612602


        CRL-2549





















        產(chǎn)品咨詢

        留言框

        • 產(chǎn)品:

        • 您的單位:

        • 您的姓名:

        • 聯(lián)系電話:

        • 常用郵箱:

        • 省份:

        • 詳細(xì)地址:

        • 補(bǔ)充說(shuō)明:

        • 驗(yàn)證碼:

          請(qǐng)輸入計(jì)算結(jié)果(填寫(xiě)阿拉伯?dāng)?shù)字),如:三加四=7
        聯(lián)系方式

        郵箱:xiangfbio@163.com

        地址:上海市虹口區(qū)四平路710號(hào)7層

        咨詢熱線

        400-821-8510

        (周一至周日9:00- 19:00)

        在線咨詢
        • 掃一掃 微信咨詢

        Copyright©2025 上海復(fù)祥生物科技有限公司 All Right Reserved    備案號(hào):滬ICP備10013034號(hào)-2     sitemap.xml
        技術(shù)支持:化工儀器網(wǎng)    管理登陸
        主站蜘蛛池模板: 国产亚洲精品xxx| 不卡精品国产_亚洲人成在线 | 一区免费在线观看| 免费人妻av无码专区| 亚洲国产美女在线观看| 无码少妇精品一区二区免费动态| 国产亚洲免费的视频看| 国产亚洲精品无码拍拍拍色欲| 无码免费又爽又高潮喷水的视频| 亚洲国产成人a精品不卡在线| 婷婷国产偷v国产偷v亚洲| 亚洲第一永久AV网站久久精品男人的天堂AV | 国产乱子伦精品免费女| 亚洲人成国产精品无码| 亚洲综合久久1区2区3区| 亚洲啪啪免费视频| 亚洲av永久无码精品三区在线4| 一二三四视频在线观看中文版免费 | 99久久成人国产精品免费| 色窝窝免费一区二区三区| 亚洲色欲色欱wwW在线| 全黄大全大色全免费大片| 亚洲人成在线影院| 老司机精品视频免费| 日韩不卡免费视频| 99亚洲乱人伦aⅴ精品| 亚洲色偷偷综合亚洲AVYP| 2022久久国产精品免费热麻豆| 久久精品亚洲男人的天堂| 免费国产成人18在线观看| 亚洲人成网网址在线看| 亚洲AV网站在线观看| 色天使亚洲综合在线观看| 亚洲伊人成无码综合网 | 中文字幕亚洲乱码熟女一区二区 | 国产一级一片免费播放| 久久99久久成人免费播放| 亚洲日韩涩涩成人午夜私人影院| 国产成人免费视频| 亚洲成熟xxxxx电影| 中文字幕高清免费不卡视频|